Vitalhub Corp.
TSX:VHI.TOMedical - Healthcare Information Services
+$0.04 today
- Market cap
- $421.84M
- Beta
- 0.77
- P/E (TTM)
- 62.1
- EPS (TTM)
- $0.12
Volume 0.23M
Average 0.41M
VHI.TO EBITDA Margin
EBITDA as a percentage of revenue.
Vitalhub Corp.TSX: VHI.TO
EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026
EBITDA Margin widens to 24.3%
EBITDA Margin was 24.3% in Q1 FY2026, up 7.3 pp from a year earlier. On a trailing-twelve-month basis it was 20.3%, up 3.9 pp year over year. Over 3 fiscal years it widened by 8.2 pp.
Context
- EBITDA Margin widened in 2 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 7 analysts of 16.1% for the fiscal year ending Dec 2026, down from 21.3% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- 24.3%+1.2 pp QoQ
- Last fiscal yearDec 2025
- 21.3%+4.0 pp YoY
- LTMMar 2026
- 20.3%+3.9 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +7.3 pp | +10.6 pp | +3.3 pp |
| 1 year | +4.0 pp | -5.2 pp | -9.2 pp |
| 3 years | +8.2 pp | -1.3 pp | -9.5 pp |
| 5 years | -4.6 pp | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 21.3%
- Year-over-year change
- +4.0pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 21.3% | +4.0pp |
| FY2024 | 2024-12-31 | 17.4% | -2.4pp |
| FY2023 | 2023-12-31 | 19.8% | +6.6pp |
| FY2022 | 2022-12-31 | 13.1% | +8.6pp |
| FY2021 | 2021-12-31 | 4.5% | — |
EBITDA Margin vs competitors
How VHI.TO compares with its peers on the latest reported figures
- VHI.TO's LTM Mar 2026 EBITDA Margin of 20.3% is the 3rd highest of the 7 companies compared; the peer median is 15.9%.
- Its year-over-year change of +3.9 pp is the 3rd highest of 7, against a peer median of -5.5 pp.
- Over three fiscal years its change of +8.2 pp compares with a peer median of +12.9 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 49.3% | +16.9 pp | -11.3 pp | |
| LTM Mar 2026 | 23.1% | +19.6 pp | +126.3 pp | |
| LTM Mar 2026 | 20.3% | +3.9 pp | +8.2 pp | |
| LTM Mar 2026 | 19.0% | -5.2 pp | +22.3 pp | |
| LTM Mar 2026 | 12.8% | -5.8 pp | +3.5 pp | |
| LTM Mar 2026 | 3.1% | -11.9 pp | +39.6 pp | |
| LTM Mar 2026 | -1275.3% | -390.0 pp | -37.5 pp | |
| Peer median (excluding VHI.TO) | 15.9% | -5.5 pp | +12.9 pp | |
Competitors are the stored peer set for VHI.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 24.66M | 39.97M | 52.51M | 68.59M | 108.97M |
| Cost of Revenue | 5.24M | 7.03M | 9.7M | 13.1M | 32.46M |
| Gross Profit | 19.43M | 32.94M | 42.81M | 55.49M | 76.51M |
| Gross Margin | 78.8% | 82.4% | 81.5% | 80.9% | 70.2% |
| Research & Development | 6.05M | 10.43M | 12.17M | 15.23M | 28.95M |
| Selling, General & Admin | 10.41M | 13.97M | 18.8M | 24.56M | 35.39M |
| Operating Expenses | 19.13M | 28.28M | 42.81M | 45.75M | 64.34M |
| Depreciation & Amortization | 2.68M | 3.87M | 4.98M | 5.96M | 11.08M |
| EBITDA | 1.12M | 5.25M | 10.38M | 11.9M | 23.25M |
| EBITDA Margin | 4.5% | 13.1% | 19.8% | 17.4% | 21.3% |
| Operating Income | 324.33K | 4.66M | 6.86M | 9.74M | 12.17M |
| Operating Margin | 1.3% | 11.7% | 13.1% | 14.2% | 11.2% |
| Interest Income | 29.55K | 0 | 489.57K | 1.95M | 2.42M |
| Interest Expense | 82.43K | 70.35K | 71.98K | 43.01K | 70.35K |
| Other Income / Expenses | (1.94M) | (6.28M) | (1.53M) | (3.85M) | (6.27M) |
| Income Before Tax | (1.61M) | 1.31M | 5.33M | 5.9M | 5.9M |
| Pre-Tax Margin | -6.5% | 3.3% | 10.1% | 8.6% | 5.4% |
| Income Tax Expense | 333.08K | 92.08K | 778.25K | 2.9M | (209.56K) |
| Net Income | (1.95M) | 1.21M | 4.55M | 3M | 6.11M |
| Net Margin | -7.9% | 3.0% | 8.7% | 4.4% | 5.6% |
| EPS (Basic) | (0.05) | 0.03 | 0.10 | 0.06 | 0.10 |
| EPS (Diluted) | (0.05) | 0.03 | 0.10 | 0.06 | 0.10 |
| Weighted Avg Shares | 36.4M | 41.49M | 43.65M | 49.2M | 58.54M |
| Weighted Avg Shares (Diluted) | 36.4M | 42.56M | 46.6M | 50.93M | 60.29M |
Vitalhub Corp.
TSX:VHI.TO
Intrinsic Alpha fair value
Locked
Current Price
$6.66
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.